This study investigates metastatic pancreatic cancer. It looks at the combination of different treatments to find out how safe and effective they are.
The study evaluates the safety and how well the combined treatments work. It checks if the treatments are tolerated and looks at the immune response.
- Who can participate: Adults who have been diagnosed with pancreatic ductal adenocarcinoma and have either recurrent or metastatic disease may participate. Participants should have a good performance status and meet specific health criteria.
- Study details: Participants will receive a combination of investigational treatments. Some participants may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand